Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 01/07/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 760 publications

Dose response of PTH and FGF23 to paricalcitol in patients with end-stage renal failure on chronic intermittent hemodialysis.

Dose response of PTH and FGF23 to paricalcitol in patients with end-stage renal failure on chronic intermittent hemodialysis.

Journal: Clinical nephrology
Published: December 11, 2025

Vitamin D receptor modulates autophagy via miR-20a-5p/ATG16L1 axis to alleviate lipopolysaccharide-induced acute kidney injury.

Vitamin D receptor modulates autophagy via miR-20a-5p/ATG16L1 axis to alleviate lipopolysaccharide-induced acute kidney injury.

Journal: Renal failure
Published: October 28, 2025

ROS-responsive graphene-hyaluronic acid nanomedicine for targeted therapy in renal ischemia/reperfusion injury.

ROS-responsive graphene-hyaluronic acid nanomedicine for targeted therapy in renal ischemia/reperfusion injury.

Journal: Theranostics
Published: June 29, 2025

Attenuating amiodarone-induced lung toxicity by the vitamin D receptor activator paricalcitol in rats: targeting TLR4/NF-κB/HIF-1α and TGF-β/Smad signaling pathways.

Attenuating amiodarone-induced lung toxicity by the vitamin D receptor activator paricalcitol in rats: targeting TLR4/NF-κB/HIF-1α and TGF-β/Smad signaling pathways.

Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: June 22, 2025

Severe consequences of uncontrolled tertiary hyperparathyroidism in a limited resources setting: a case report.

Severe consequences of uncontrolled tertiary hyperparathyroidism in a limited resources setting: a case report.

Journal: Frontiers in nephrology
Published: June 12, 2025

NSUN2-mediated m5C modification of KDM6B mRNA enhances osteoclast differentiation and promotes breast cancer bone metastasis.

NSUN2-mediated m5C modification of KDM6B mRNA enhances osteoclast differentiation and promotes breast cancer bone metastasis.

Journal: Cancer letters
Published: June 03, 2025

KDM6B enhances anti-PD-L1 immunotherapy efficacy by increasing CD8+ T-cell infiltration in colorectal cancer.

KDM6B enhances anti-PD-L1 immunotherapy efficacy by increasing CD8+ T-cell infiltration in colorectal cancer.

Journal: Journal of Cancer
Published: May 30, 2025

Corrigendum: Paricalcitol alleviates intestinal ischemia-reperfusion injury via inhibition of the ATF4-CHOP pathway.

Corrigendum: Paricalcitol alleviates intestinal ischemia-reperfusion injury via inhibition of the ATF4-CHOP pathway.

Journal: Frontiers in pharmacology
Published: May 20, 2025

Paricalcitol and hydroxychloroquine modulates extracellular matrix and enhance chemotherapy efficacy in pancreatic cancer.

Paricalcitol and hydroxychloroquine modulates extracellular matrix and enhance chemotherapy efficacy in pancreatic cancer.

Journal: Research square
Published: May 19, 2025

Paricalcitol-mediated vitamin D receptor activation attenuates neuronal ferroptosis via cAMP-PKA-DRP1 signaling pathway after intracerebral hemorrhage.

Paricalcitol-mediated vitamin D receptor activation attenuates neuronal ferroptosis via cAMP-PKA-DRP1 signaling pathway after intracerebral hemorrhage.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: April 30, 2025

Paricalcitol and hydroxychloroquine modulates extracellular matrix and enhance chemotherapy efficacy in pancreatic cancer.

Paricalcitol and hydroxychloroquine modulates extracellular matrix and enhance chemotherapy efficacy in pancreatic cancer.

Journal: Cancer gene therapy
Published: April 22, 2025

Real-world data from a national survey on management of CKD-associated osteoporosis among Italian nephrologists.

Real-world data from a national survey on management of CKD-associated osteoporosis among Italian nephrologists.

Journal: Archives of osteoporosis
Published: February 23, 2025
Showing 1-12 of 760

Last Updated: 01/07/2026